vimarsana.com
Home
Live Updates
Is the 6MWT still the best endpoint for Pompe disease clinical trials? : vimarsana.com
Is the 6MWT still the best endpoint for Pompe disease clinical trials?
The 6-minute walk test has long been the consensus primary measure for Pompe disease drug studies, but some experts are calling for change.
Related Keywords
Italy ,
Barry Byrne ,
Sanofi Nexviazyme ,
Carlos Javier Alm ,
Corrado Angelini ,
Gerald Cox ,
Genzyme Myozyme ,
Powell Gene Therapy Center ,
Contract Manufacturing Organisation ,
Contract Research Organisation For Clinical Trials ,
University Of Florida ,
Neuromuscular Center ,
University Of Padua ,
Forced Vital Capacity ,
Astellas Gene Therapies ,
Spark Therapeutics ,
Clinical Trials Arena ,
Manufacturing Organisation ,
Pharmaceutical Supply ,
Event Conception ,
Research Organisation ,
vimarsana.com © 2020. All Rights Reserved.